Nobel Laureate Changed Cancer Treatments

We bring you a special episode, celebrating the award of this year's Nobel Prize in Physiology or Medicine to Tasuku Honjo, Distinguished Professor at Kyoto University. His basic research has led to the development and clinical applications of Opdivo, a groundbreaking new anti-cancer drug that works with immune cells. It has given hope to many cancer patients, and surprised clinical specialists. We'll explore what innovation Opdivo has brought to cancer treatment, and what challenges remain.